The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Rafael Fonseca

Department of Hematology-Oncology

Mayo Clinic

13400 East Shea Boulevard

Scottsdale

USA

[email]@mayo.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Hematology-Oncology, Mayo Clinic, 13400 East Shea Boulevard, Scottsdale, USA. 2006 - 2009
  • Mayo Clinic Arizona, Scottsdale, AZ 85259, USA. 2008
  • Mayo Clinic Scottsale, 3400 East Shea Boulevard, Collaborative Research Building, 3-006, USA. 2007
  • Department of Hematology, Mayo Clinic, Rochester, Minnesota, USA. 1999 - 2004
  • Mayo Clinic Department of Hematology and Internal Medicine, Minneapolis, MN 55905, USA. 2002 - 2003
  • Mayo Clinic Division of Hematology, The Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, USA. 2003

References

  1. International Myeloma Working Group molecular classification of multiple myeloma: spotlight review. Fonseca, R., Bergsagel, P.L., Drach, J., Shaughnessy, J., Gutierrez, N., Stewart, A.K., Morgan, G., Van Ness, B., Chesi, M., Minvielle, S., Neri, A., Barlogie, B., Kuehl, W.M., Liebisch, P., Davies, F., Chen-Kiang, S., Durie, B.G., Carrasco, R., Sezer, O., Reiman, T., Pilarski, L., Avet-Loiseau, H. Leukemia (2009) [Pubmed]
  2. Consolidation therapy with bortezomib/lenalidomide/ dexamethasone versus bortezomib/dexamethasone after a dexamethasone-based induction regimen in patients with multiple myeloma: a randomized phase III trial. Fonseca, R., Rajkumar, S.V. Clin. Lymphoma. Myeloma (2008) [Pubmed]
  3. Strategies for risk-adapted therapy in myeloma. Fonseca, R. Hematology. Am. Soc. Hematol. Educ. Program (2007) [Pubmed]
  4. Waldenström macroglobulinaemia. Fonseca, R., Hayman, S. Br. J. Haematol. (2007) [Pubmed]
  5. Targeted therapeutics for multiple myeloma: the arrival of a risk-stratified approach. Fonseca, R., Stewart, A.K. Mol. Cancer Ther. (2007) [Pubmed]
  6. Prognostic factors and staging in multiple myeloma. Fonseca, R., San Miguel, J. Hematol. Oncol. Clin. North Am. (2007) [Pubmed]
  7. Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myeloma. Fonseca, R., Van Wier, S.A., Chng, W.J., Ketterling, R., Lacy, M.Q., Dispenzieri, A., Bergsagel, P.L., Rajkumar, S.V., Greipp, P.R., Litzow, M.R., Price-Troska, T., Henderson, K.J., Ahmann, G.J., Gertz, M.A. Leukemia (2006) [Pubmed]
  8. Genetics and cytogenetics of multiple myeloma: a workshop report. Fonseca, R., Barlogie, B., Bataille, R., Bastard, C., Bergsagel, P.L., Chesi, M., Davies, F.E., Drach, J., Greipp, P.R., Kirsch, I.R., Kuehl, W.M., Hernandez, J.M., Minvielle, S., Pilarski, L.M., Shaughnessy, J.D., Stewart, A.K., Avet-Loiseau, H. Cancer Res. (2004) [Pubmed]
  9. Clinical and biologic implications of recurrent genomic aberrations in myeloma. Fonseca, R., Blood, E., Rue, M., Harrington, D., Oken, M.M., Kyle, R.A., Dewald, G.W., Van Ness, B., Van Wier, S.A., Henderson, K.J., Bailey, R.J., Greipp, P.R. Blood (2003) [Pubmed]
  10. The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma. Fonseca, R., Debes-Marun, C.S., Picken, E.B., Dewald, G.W., Bryant, S.C., Winkler, J.M., Blood, E., Oken, M.M., Santana-Dávila, R., González-Paz, N., Kyle, R.A., Gertz, M.A., Dispenzieri, A., Lacy, M.Q., Greipp, P.R. Blood (2003) [Pubmed]
  11. Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients. Fonseca, R., Blood, E.A., Oken, M.M., Kyle, R.A., Dewald, G.W., Bailey, R.J., Van Wier, S.A., Henderson, K.J., Hoyer, J.D., Harrington, D., Kay, N.E., Van Ness, B., Greipp, P.R. Blood (2002) [Pubmed]
  12. Laboratory correlates in multiple myeloma: how useful for prognosis?. Fonseca, R., Conte, G., Greipp, P.R. Blood Rev. (2001) [Pubmed]
  13. Cytogenetic abnormalities in multiple myeloma. Fonseca, R., Coignet, L.J., Dewald, G.W. Hematol. Oncol. Clin. North Am. (1999) [Pubmed]
 
WikiGenes - Universities